Transcription of US-19233 ------------------------- DOSAGE AND ...
{{id}} {{{paragraph}}}
Example: biology
US-19233 ------------------------- DOSAGE AND ...
US-19233 ------------------------- DOSAGE AND ADMINISTRATION -------------------------- HIGHLIGHTS OF prescribing information Initiate treatment with 180 mg oral loading dose following an ACS event. Continue treatment with 90 mg twice daily during the first year after an ACS. These highlights do not include all the information needed to use brilinta . event. After one year, administer 60 mg twice daily. ( ). safely and effectively. See full prescribing information for brilinta . Use brilinta with a daily maintenance dose of aspirin of 75-100 mg. brilinta (ticagrelor) tablets, for oral use ( , ). Initial Approval: 2011. ------------------------ DOSAGE FORMS AND STRENGTHS ------------------------ 60 mg and 90 mg tablets (3). WARNING: (A) BLEEDING RISK, and (B) ASPIRIN DOSE AND.
FULL PRESCRIBING INFORMATION WARNING: (A) BLEEDING RISK, (B) ASPIRIN DOSE AND BRILINTA EFFECTIVENESS A. BLEEDING RISK • BRILINTA, like other antiplatelet agents, can cause significant, sometimes fatal bleeding (5.1, 6.1).
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: